These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7756713)

  • 1. Lamotrigine: an antiepileptic agent for the treatment of partial seizures.
    Gilman JT
    Ann Pharmacother; 1995 Feb; 29(2):144-51. PubMed ID: 7756713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
    Goa KL; Ross SR; Chrisp P
    Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy.
    Gamble C; Williamson PR; Chadwick DW; Marson AG
    Neurology; 2006 May; 66(9):1310-7. PubMed ID: 16682660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.
    Duchowny M; Pellock JM; Graf WD; Billard C; Gilman J; Casale E; Womble G; Risner M; Manasco P
    Neurology; 1999 Nov; 53(8):1724-31. PubMed ID: 10563619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine.
    Burstein AH
    Pharmacotherapy; 1995; 15(2):129-43. PubMed ID: 7624259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
    Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures.
    Boas J; Dam M; Friis ML; Kristensen O; Pedersen B; Gallagher J
    Acta Neurol Scand; 1996 Oct; 94(4):247-52. PubMed ID: 8937535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
    Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
    Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin and lamotrigine: novel antiepileptic drugs.
    Btaiche IF; Woster PS
    Am J Health Syst Pharm; 1995 Jan; 52(1):61-9. PubMed ID: 12879525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
    Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
    Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.
    Messenheimer J; Ramsay RE; Willmore LJ; Leroy RF; Zielinski JJ; Mattson R; Pellock JM; Valakas AM; Womble G; Risner M
    Epilepsia; 1994; 35(1):113-21. PubMed ID: 8112232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
    Smith D; Baker G; Davies G; Dewey M; Chadwick DW
    Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM
    Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine--an update.
    Brodie MJ
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S6-9. PubMed ID: 8951213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine update and its use in mood disorders.
    Hurley SC
    Ann Pharmacother; 2002 May; 36(5):860-73. PubMed ID: 11978166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.